Rat colon carcinoma cells that survived systemic immune surveillance are less sensitive to NK-cell mediated apoptosis

Clinical and Experimental Metastasis

Volumn 20, Issue 8, 2003, Pages 713-722

  Velthuis, Jurjen H L ^a   Stitzinger, Miranda ^a   Aalbers, Remco I J M ^b   De Bont, Hans J G M ^a   Mulder, Gerard J ^a   Kuppen, Peter J K ^b   Nagelkerke, J Fred ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; CD95L; Immune surveillance; NK cells; TRAIL

Indexed keywords

FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN; FLICE INHIBITORY PROTEIN; GRANZYME B; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PHYCOCYANIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL SELECTION; CELL STRAIN CC531S M1; CELL STRAIN CC531S M2; CELL SURVIVAL; CELL TYPE; COLON CARCINOMA; CONTROLLED STUDY; IMMUNOSURVEILLANCE; IN VIVO STUDY; JUGULAR VEIN; LIVER CELL; LUNG METASTASIS; LYMPHOCYTE MIGRATION; MALE; METASTASIS POTENTIAL; MOUSE; NATURAL KILLER CELL; NONHUMAN; RAT;

EID: 0346880458     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CLIN.0000006818.27267.03     Document Type: Article

References (26)

1. Portera CA, Berman RS, Ellis LM. Molecular determinants of colon cancer metastasis. Surg Oncol 1998; 7: 183-95.
2. Trapani JA, Jans DA, Jans PJ et al. Efficient nuclear targeting of granzyme B and the nuclear consequences of apoptosis induced by granzyme B and perform are caspase-dependent, but cell death is caspase-independent. J Biol Chem 1998; 273: 27934-38.
3. Metkar SS, Wang B, Aguilar-Santelises M et al. Cytotoxic cell granule-mediated apoptosis: Perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation. Immunity 2002; 16: 417-28.
4. Nicholson DW, Thornberry NA. Caspases: killer proteases. Trends Biochem Sci 1997; 22: 299-306.
5. Wallach D, Kovalenko AV, Varfolomeev EE, Boldin MP. Death-inducing functions of ligands of the tumor necrosis factor family: A Sanhedrin verdict. Curr Opin Immunol 1998; 10: 279-88.
6. Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science 1998; 281: 1305-8.
7. Velthuis JH, Rouschop KM, de Bont HJ et al. Distinct Intracellular Signaling in Tumor Necrosis Factor-related Apoptosis-inducing Ligand-and CD95 Ligand-mediated Apoptosis. J Biol Chem 2002; 277: 24631-7.
8. Degli-Esposti M. To die or not to die - the quest of the TRAIL receptors. J Leuk Biol 1999; 65: 535-42.
9. Jo M, Kim TH, Seol DW et al. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med 2000; 6: 564-7.
10. Basse PH, Whiteside TL, Chambers W, Herberman RB. Therapeutic activity of NK cells against tumors. Int Rev Immunol 2001; 20: 439-501.
11. Griffini P, Smorenburg SM, Verbeek FJ, Van Noorden CJ. Three-dimensional reconstruction of colon carcinoma metastases in liver. J Microsc 1997; 187: 12-21.
12. Marquet RL, Westbroek DL, Jeekel J. Interferon treatment of a transplantable rat colon adenocarcinoma: Importance of tumor site. Int J Cancer 1984; 33: 689-92.
13. Medema JP, de Jong J, van Hall T et al. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein. J Exp Med 1999; 190: 1033-8.
14. Kayagaki N, Yamaguchi N, Nakayama M et al. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J Immunol 1999; 163: 1906-13.
15. Kuppen PJ, Basse PH, Goldfarb RH et al. The infiltration of experimentally induced lung metastases of colon carcinoma CC531 by adoptively transferred interleukin-2-activated natural killer cells in Wag rats. Int J Cancer 1994; 56: 574-9.
16. Wexler H. Accurate identification of experimental pulmonary metastases. J Natl Cancer Inst 1966; 36: 641-5.
17. Hagenaars M, Koelemij R, Ensink NG et al. The development of novel mouse monoclonal antibodies against the CC531 rat colon adenocarcinoma. Clin Exp Metastasis 2000; 18: 281-9.
18. Velthuis JH, De-Bont HJ, Medema JP et al. Interleukin-2 activated NK cells do not use the CD95L-and TRAIL-pathways in the rapid induction of apoptosis of rat colon carcinoma CC531s cells. Immunobiology 2003; 207: 115-27.
19. Blom WM, De-Bont HJ, Meijerman I et al. Interleukin-2-activated natural killer cells can induce both apoptosis and necrosis in rat hepatocytes. Hepatology 1999; 29: 785-92.
20. Fidler IJ, Gersten DM, Budmen MB. Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity. Cancer Res 1976; 36: 3160-5.
21. Heuff G, Oldenburg HS, Boutkan H et al. Enhanced tumour growth in the rat liver after selective elimination of Kupffer cells. Cancer Immunol Immunother 1993; 37: 125-30.
22. Thomas C, Nijenhuis AM, Dontje B et al. Tumoricidal response of liver macrophages isolated from rats bearing liver metastases of colon adenocarcinoma. J Leuk Biol 1995; 57: 617-23.
23. Smyth MJ, Thia KY, Cretney E et al. Perforin is a major contributor to NK cell control of tumor metastasis. J Immunol 1999; 162: 6658-62.
24. Walczak H, Miller RE, Ariail K et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 1999; 5: 157-63.
25. Rensing-Ehl A, Frei K, Flury R et al. Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo. Eur J Immunol 1995; 25: 2253-8.
26. Takeda K, Hayakawa Y, Smyth MJ et al. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 2001; 7: 94-100.